This randomized clinical trial evaluates the safety and efficacy of basimglurant modified-release vs placebo as adjunctive therapy to ongoing antidepressant medication therapy in patients with major depressive disorder who had inadequate response within the current episode.
This meta-analysis uses 4 operational categories of brief psychotic episodes to look at the risk of recurrence of psychoses after a patient experiences a brief psychotic first episode.
This study of patients with major depressive disorder reports that a more densely connected symptom network is associated with persistent depression.
This study determines the neural correlates of disturbed body awareness in borderline personality disorder and its associations with emotional dysregulation.
Among 75 medication-free patients with remitted major depressive disorder and no relevant comorbidity, this prospective cohort study tests the hypothesis that RSATL-SCSR connectivity for self-blaming relative to other-blaming emotions predicts subsequent recurrence of depressive episodes.
This randomized trial suggests that the type of family therapy matters in the treatment of adolescent-onset anorexia nervosa.
McGrath et al identify a candidate neuroimaging treatment-specific biomarker that predicts differential outcome to either medication or psychotherapy.
This randomized clinical trial compares the efficacy of light treatment, both as monotherapy and in combination with fluoxetine, with a sham placebo condition for adults with nonseasonal major depressive disorder.